• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响纳米颗粒在肺部药物传递中命运的物理化学性质。

Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.

出版信息

Drug Discov Today. 2020 Jan;25(1):150-159. doi: 10.1016/j.drudis.2019.09.023. Epub 2019 Oct 7.

DOI:10.1016/j.drudis.2019.09.023
PMID:31600580
Abstract

The inhaled delivery of nanomedicines has attracted much attention in the treatment of lung diseases or systemic diseases. However, there is a lack of understanding about their fate upon lung delivery. Thus, the objective of this review is to summarize physicochemical properties affecting the fate of nanoparticles after deposition in the lung. First, physiological structure and characteristics of the lung are described. Thereafter, physicochemical properties that could influence the clearance and translocation of nanoparticles in the lung are discussed, including particle size, surface charge and surface hydrophilicity. It is believed that, with a better understanding of the fate of nanoparticles in the lung, it will broaden their application in inhalation for a better therapeutic effect in the future.

摘要

吸入式纳米药物传递在肺部疾病或全身性疾病的治疗中受到了广泛关注。然而,人们对其在肺部给药后的命运缺乏了解。因此,本综述的目的是总结影响纳米颗粒在肺部沉积后命运的物理化学性质。首先,描述了肺部的生理结构和特征。然后,讨论了可能影响纳米颗粒在肺部清除和转移的物理化学性质,包括粒径、表面电荷和表面亲水性。相信通过更好地了解纳米颗粒在肺部的命运,将拓宽它们在吸入式给药中的应用,以在未来获得更好的治疗效果。

相似文献

1
Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery.影响纳米颗粒在肺部药物传递中命运的物理化学性质。
Drug Discov Today. 2020 Jan;25(1):150-159. doi: 10.1016/j.drudis.2019.09.023. Epub 2019 Oct 7.
2
Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants.影响纳米颗粒命运和肺表面活性剂生理功能的物理化学性质。
Acta Biomater. 2022 Mar 1;140:76-87. doi: 10.1016/j.actbio.2021.11.034. Epub 2021 Nov 26.
3
Physicochemical characteristics of nanomaterials that affect pulmonary inflammation.影响肺部炎症的纳米材料的物理化学特性。
Part Fibre Toxicol. 2014 Apr 11;11:18. doi: 10.1186/1743-8977-11-18.
4
Inhaled nanoparticles--a current review.吸入性纳米颗粒——当前综述
Int J Pharm. 2008 May 22;356(1-2):239-47. doi: 10.1016/j.ijpharm.2008.02.011. Epub 2008 Feb 16.
5
The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.肺部给药中的纳米尺度。第1部分:沉积、归宿、毒理学及效应。
Expert Opin Drug Deliv. 2007 Nov;4(6):595-606. doi: 10.1517/17425247.4.6.595.
6
Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona.纳米颗粒的物理化学性质调控其跨肺表面活性剂单层的转运及脂蛋白冠的形成。
ACS Nano. 2013 Dec 23;7(12):10525-33. doi: 10.1021/nn4054683. Epub 2013 Nov 26.
7
Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.用于肺部递药的工程化 PLGA 纳米和微载体:挑战与前景。
J Pharm Pharmacol. 2012 Sep;64(9):1217-35. doi: 10.1111/j.2042-7158.2012.01486.x. Epub 2012 Mar 12.
8
Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.在离体肺模型中使用可雾化纳米颗粒进行肺部药物递送。
Int J Pharm. 2009 Feb 9;367(1-2):169-78. doi: 10.1016/j.ijpharm.2008.09.017. Epub 2008 Sep 19.
9
Rapid translocation of nanoparticles from the lung airspaces to the body.纳米颗粒从肺部空气腔快速转移到体内。
Nat Biotechnol. 2010 Dec;28(12):1300-3. doi: 10.1038/nbt.1696. Epub 2010 Nov 7.
10
Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics.吸入式西地那非纳米复合材料:肺部蓄积与肺药代动力学
Pharm Dev Technol. 2016 Dec;21(8):961-971. doi: 10.3109/10837450.2015.1086369. Epub 2015 Oct 1.

引用本文的文献

1
Air pollution and alveolar health.空气污染与肺泡健康。
Eur Respir Rev. 2025 Sep 3;34(177). doi: 10.1183/16000617.0280-2024. Print 2025 Jul.
2
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.用于治疗肺部感染的基于可吸入纳米颗粒的递送系统及克服屏障的策略。
Drug Deliv. 2025 Dec;32(1):2544683. doi: 10.1080/10717544.2025.2544683. Epub 2025 Aug 11.
3
[Advances in inhalable nano-formulations].[可吸入纳米制剂的进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 3;54(4):511-521. doi: 10.3724/zdxbyxb-2024-0650.
4
Exploring the Potential of PLGA Nanoparticles for Enhancing Pulmonary Drug Delivery.探索聚乳酸-羟基乙酸共聚物纳米颗粒在增强肺部药物递送方面的潜力。
Mol Pharm. 2025 Jul 7;22(7):3542-3562. doi: 10.1021/acs.molpharmaceut.5c00118. Epub 2025 Jun 6.
5
Impact of pH-Responsive Cisplatin/Ribavirin-Loaded Monodispersed Magnetic Silica Nanocomposite on A549 Lung Cancer Cells.pH响应性顺铂/利巴韦林负载单分散磁性二氧化硅纳米复合材料对A549肺癌细胞的影响
Pharmaceutics. 2025 May 9;17(5):631. doi: 10.3390/pharmaceutics17050631.
6
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy.含环丙沙星的纳米颗粒干粉吸入器用于增强靶向抗菌治疗
Pharmaceutics. 2025 Apr 7;17(4):486. doi: 10.3390/pharmaceutics17040486.
7
A phenotypic drug discovery approach by latent interaction in deep learning.一种基于深度学习中潜在相互作用的表型药物发现方法。
R Soc Open Sci. 2024 Oct 23;11(10):240720. doi: 10.1098/rsos.240720. eCollection 2024 Oct.
8
Recent strategies for enhanced delivery of mRNA to the lungs.近期增强mRNA肺部递送的策略。
Nanomedicine (Lond). 2025 May;20(9):1043-1069. doi: 10.1080/17435889.2025.2485669. Epub 2025 Apr 7.
9
Treatment of lung diseases nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?肺部疾病的治疗——纳米颗粒与纳米机器人:它们是克服现有治疗方法的可行替代方案吗?
Mater Today Bio. 2025 Feb 26;31:101616. doi: 10.1016/j.mtbio.2025.101616. eCollection 2025 Apr.
10
Citrullination of NF-κB p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury.PAD2对NF-κB p65的瓜氨酸化作为急性肺损伤中调节巨噬细胞极化的新型治疗靶点
Adv Sci (Weinh). 2025 May;12(18):e2413253. doi: 10.1002/advs.202413253. Epub 2025 Mar 14.